403 related articles for article (PubMed ID: 3484491)
1. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
Umetsu DT; Katzen D; Jabara HH; Geha RS
J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
[TBL] [Abstract][Full Text] [Related]
2. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
3. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
4. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.
Geppert TD; Lipsky PE
J Immunol; 1987 Jan; 138(2):385-92. PubMed ID: 3098840
[TBL] [Abstract][Full Text] [Related]
5. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
[TBL] [Abstract][Full Text] [Related]
6. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
Le JM; Vilcek J
J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
[TBL] [Abstract][Full Text] [Related]
7. Antigen-presenting capacity of rheumatoid synovial fibroblasts.
Boots AM; Wimmers-Bertens AJ; Rijnders AW
Immunology; 1994 Jun; 82(2):268-74. PubMed ID: 7927499
[TBL] [Abstract][Full Text] [Related]
8. Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding.
Lyons CR; Ball EJ; Toews GB; Weissler JC; Stastny P; Lipscomb MF
J Immunol; 1986 Aug; 137(4):1173-80. PubMed ID: 2426354
[TBL] [Abstract][Full Text] [Related]
9. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
[TBL] [Abstract][Full Text] [Related]
10. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells.
Brozek C; Umetsu D; Schneeberger E; Geha RS
J Immunol; 1984 Mar; 132(3):1144-50. PubMed ID: 6607279
[TBL] [Abstract][Full Text] [Related]
12. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
13. Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids.
Rhodes J; Ivanyi J; Cozens P
Eur J Immunol; 1986 Apr; 16(4):370-5. PubMed ID: 2422040
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex restriction of tetanus toxoid-specific human T lymphocyte clones.
Schmitt C; Cogné M; Agrapart M; Ballet JJ
Eur J Immunol; 1984 Dec; 14(12):1131-6. PubMed ID: 6083872
[TBL] [Abstract][Full Text] [Related]
15. Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes.
Moreno J; Lipsky PE
J Immunol; 1986 May; 136(10):3579-87. PubMed ID: 3084635
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific and polyclonal immunoglobulin production induced by a cloned tetanus toxoid-specific T cell line.
Friedman SM; Principato MA; Thompson GS; Teichman F
J Immunol; 1983 Mar; 130(3):1164-70. PubMed ID: 6185573
[TBL] [Abstract][Full Text] [Related]
17. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific and -nonspecific mitogenic signals in the activation of human T cell clones.
Nisbet-Brown ER; Lee JW; Cheung RK; Gelfand EW
J Immunol; 1987 Jun; 138(11):3713-9. PubMed ID: 2953789
[TBL] [Abstract][Full Text] [Related]
19. T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to T cell proliferation.
Meuer SC; Meyer zum Büschenfelde KH
J Immunol; 1986 Jun; 136(11):4106-12. PubMed ID: 3084655
[TBL] [Abstract][Full Text] [Related]
20. "Tolerization" of human T-helper cell clones by chronic exposure to alloantigen: culture conditions dictate autocrine proliferative status but not acquisition of cytotoxic potential and suppressor-induction capacity.
Pawelec G; Brocker T; Busch FW; Bühring HJ; Fernandez N; Schneider EM; Wernet P
J Mol Cell Immunol; 1988; 4(1):21-34. PubMed ID: 2977949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
